Skip to content
MedsAcross

Medicine

Combogesic 325 mg/97.5 mg tablet

Acetaminophen and Ibuprofen · Oral · AFT Pharmaceuticals
Available on requestPrescription onlyUS FDA

Combogesic 325 mg/97.5 mg tablet is a prescription medicine containing Acetaminophen and Ibuprofen for oral use, marketed by AFT Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20°C to 25°C (68°F to 77°F) with excursions permitted within USP…

Key facts

Active ingredient (INN)
Acetaminophen and Ibuprofen
Brand
Combogesic
Strength
325 mg/97.5 mg
Dosage form
Tablet
Route
Oral
Packs
250 tablets, 60 tablets, 120 tablets and 2 more
Marketing authorisation holder
AFT Pharmaceuticals
Manufacturers
AFT PharmaceuticalsPreferred PharmaceuticalsHikma Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20°C to 25°C (68°F to 77°F) with excursions permitted within USP controlled room temperature of 15°C to 30°C (59°F to 86°F). Protect from moisture and light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
6 January 2025
Identifiers
RxCUI 2675760, 2675765DailyMed set ID f863558f-2a44-41f8-a6b7-271851d4c2ff, b32651c4-7fa0-415b-91eb-854aa1c28f2a, cd03b658-dba1-4a12-8f6f-ab00da499c05 +1NDC 72260-129, 0143-9432, 68788-4009 +1Application NDA209471

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
250 tablet, film coated in 1 bottle, plastic72260-129-01AFT Pharmaceuticals30 June 2026
60 tablet, film coated in 1 bottle, plastic72260-129-02AFT Pharmaceuticals30 June 2026
250 tablet, film coated in 1 bottle, plastic0143-9432-27Hikma Pharmaceuticals6 January 2025
120 tablet, film coated in 1 bottle, plastic68788-4009-1Preferred Pharmaceuticals4 September 2025
120 tablet, film coated in 1 bottle, plastic68788-4181-1Preferred Pharmaceuticals20 August 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 28 February 2020Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Acetaminophen and Ibuprofen

Clinical summary

Acetaminophen and Ibuprofen is a fixed-dose combination medicine indicated in adults for the short-term management of mild to moderate acute pain. It is available as tablets and injection for oral and intravenous use. MedsAcross supplies Acetaminophen and Ibuprofen for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Acetaminophen and Ibuprofen

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Combogesic 325 mg/97.5 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.